Merck's Keytruda succeeds in late-stage lung cancer study

(Reuters) - Merck& Co on Wednesday said its cancer drug Keytruda helped extend survival and prevented disease progression when tested in a late-stage study in combination with chemotherapy for a type of lung cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news